Received May 12, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | 1 | 030M20A | IM |
Experiencing prolonged healing at the injection site; This spontaneous case was reported by a patient and describes the occurrence of INJECTION SITE REACTION (Experiencing prolonged healing at the injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031A21A and 030M20A) for COVID-19 prophylaxis. No Medical History information was reported. On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular use) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular use) dosage was changed to 1 dosage form. In 2021, the patient experienced INJECTION SITE REACTION (Experiencing prolonged healing at the injection site). At the time of the report, INJECTION SITE REACTION (Experiencing prolonged healing at the injection site) had not resolved. Concomitant medication was not provided. Patient called to report that the injection site from her Moderna COVID-19 vaccine, received in 2021, had not healed. She had been experiencing prolonged healing at the injection site. Despite consulting multiple doctors over the years, she had not received a satisfactory explanation. She expressed concern about the unusual duration for healing and inquired if others experienced similar issues. One doctor mentioned mercury from the needle, while another ordered blood tests, which she recently completed, but results are pending. It was unknown if the patient experienced any additional symptoms or events. Treatment information was not reported.